Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Regulatory

Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing

BLO · Price

Executive Summary

  • Cannabix Technologies’ Breath Collection Unit (BCU) passed FCC electronic emissions testing and Canadian ISED standards, clearing a key regulatory hurdle for U.S. and Canadian market entry.
  • The successful test was conducted by ISO/IEC 17025‑accredited QAI Laboratories, providing an official compliance report under CFR Title 47 Part 15 and ICES‑003 Issue 7.
  • Completion of emissions testing advances the commercialization timeline for the Marijuana Breath Test (MBT) system, which pairs the BCU with proprietary breath cartridges for forensic THC detection.

Key Details

  • Regulatory Approval: FCC Part 15 (U.S.) and ISED ICES‑003 Issue 7 (Canada) electronic emissions standards met; ISO/IEC 17025 accredited test report issued.
  • Testing Facility: QAI Laboratories, British Columbia – holds Telecommunication Certification Body (TCB) designation and recognized for electrical safety evaluations in both markets.
  • Product Description: Handheld Breath Collection Unit (BCU) plus proprietary Breath Cartridges form the core hardware of the MBT system, designed to collect stable breath samples for LC‑MS analysis of recent marijuana use.
  • Strategic Partnership: Omega Laboratories Inc., a global forensic drug‑testing leader, will support commercialization and analytical validation of the MBT system in the U.S. and Canada.
  • Commercialization Impact: Passing emissions testing removes a critical barrier to market entry, allowing Cannabix to proceed with regulatory filings, manufacturing scale‑up, and sales efforts for workplaces, law enforcement, and other settings.
  • Forward‑Looking Statements: Company anticipates continued regulatory steps, potential additional agreements with distributors, and future financing to support product launch; risks include market conditions, technology protection, and successful completion of further approvals.

Notable Quotes

“The successful emissions testing of our Breath Collection Unit is a pivotal milestone that brings us significantly closer to delivering a reliable, compliant solution for detecting recent marijuana use in the workplace and law‑enforcement environments.” – Rav Mlait, CEO, Cannabix Technologies Inc.

Read the original news release →

More from Cannabix Technologies Inc.